(S)-2-(1-(9H-purin-6-ylamino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one)

(S)-2-(1-(9H-purin-6-ylamino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one)
Trade Name
Orphan Indication T-cell lymphoma
USA Market Approval USA
USA Designation Date 2017-12-18 00:00:00
Sponsor Rhizen Pharmaceuticals SA;40 Rue Fritz-Courvoisier;La Chaux-de-Fonds